The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Actiq 600 micrograms compressed lozenge with integral oromucosal applicator

Teva Pharma B.V.PA0749/195/003

Main Information

Trade NameActiq 600 micrograms compressed lozenge with integral oromucosal applicator
Active SubstancesFentanyl
Dosage FormCompressed lozenge
Licence HolderTeva Pharma B.V.
Licence NumberPA0749/195/003

Group Information

ATC CodeN02AB Phenylpiperidine derivatives
N02AB03 fentanyl


License statusAuthorised
Licence Issued23/01/2002
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Educational Materials - HCP

Educational Materials - Patient

« Back